🟡Relating to billing and reimbursement for certain medical equipment, devices, and supplies provided to Medicare enrollees; creating a criminal offense.

🟡 SB 1330: Caps medical equipment charges, leaves consent based loophole risk

What it says it does:
Protects Medicare enrollees from being overcharged for medical equipment and supplies by sellers that do not take Medicare’s set price.

What it actually changes:
Sets a 115 percent cap over the Medicare approved amount unless the patient signs a written agreement before billing and either prepays or agrees to a rental plan before delivery. Requires warnings that Medicare covers 80 percent and Medigap plans are not required to pay anything above 115 percent. Treats violations as deceptive trade practices. Intentional violations are a misdemeanor with a 500 to 1,000 dollar fine. Gives no new penalty authority to the insurance department. Effective September 1, 2025.

Who is pushing for it:
Life and health insurer trade groups, major carriers, and an affordability branded advocacy group supported the bill. The insurance department appeared on the bill. Opponents in files: Not in files.

Who benefits:
Medigap issuers and large plans gain a durable liability ceiling for charges above 115 percent, and leverage to negotiate with suppliers. Suppliers that price near Medicare’s amount get a fairer field. Patients who refuse above cap deals are protected at the counter.

Who gets left out or exposed:
Patients who sign the pre billing agreement under pressure lose the cap for that purchase and face costs their Medigap plan is not required to cover. Nonparticipating sellers that relied on high markups lose leverage unless they secure pre billing consent tied to payment. Rural areas with few participating suppliers may see limited choices.

Why this matters long term:
Creates a template that can be copied to other health services, locking in insurer non obligation above a statutory ceiling while leaving the key decision to a private consent moment. Enforcement depends on consumer complaints and small fines, not a regulator with strong tools. There is no requirement to report how often above cap agreements are used.

What to watch next:
Consent mechanics, there is no standard form, example math, or cooling off window. Penalties, small fines may not deter repeat behavior. Data, no reporting on the frequency or outcomes of above cap agreements. Access, shortage areas may pressure patients into signing or going without.

Bottom line:
SB 1330 draws a bright line at 115 percent, then opens a doorway to charge more if a patient signs before billing and ties that signature to payment. Insurers gain certainty. Honest suppliers can compete. Patients are protected only if they decline the above cap deal at the counter.

Questions to ask lawmakers:

1. Did you consider requiring a simple, standard consent form with example numbers so people know exactly what they will owe before they sign
2. What was the rationale for using small fines and general consumer law instead of giving the insurance department specific penalty tools for repeat bad actors
3. How will the state track whether above cap agreements are being used a lot in rural or low income areas where people have fewer supplier options


#SB1330 #TexasPolicy #WatchTheRules #TexasHealthcare #Medicare #ConsumerProtection